Effect of Dietary Fiber on Glucose & Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM)
NCT ID: NCT00825383
Last Updated: 2013-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
1993-01-31
1995-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of NVFS on GC in Individuals With DM: SR & MA of RCTs
NCT03259724
The Effect of Viscous Fiber on Glycemic Control in Individuals With Diabetes
NCT02629263
Effect of Fiber on Glycemic Index
NCT02615327
Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes Mellitus
NCT02204384
Fiber Effects on Glycemic Index
NCT02831738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
High Fiber Diet
High Fiber and Moderate Fiber Diets
Dietary
2
Moderate Fiber Diet
High Fiber and Moderate Fiber Diets
Dietary
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Fiber and Moderate Fiber Diets
Dietary
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 35 to 80 years
* stable oral hypoglycemic treatment for at least one month
* fasting triglycerides \< 500 mg/dl
Exclusion Criteria
* insulin dependent diabetes
* hepatic disease
* significant hepatic dysfunction
* signifiacnt renal dysfunction
* presence of significant hematological, neurological, cardiovascular or gastrointestinal disorder, unless stable for past 6 months,
* serious intercurrent illness or anticipated major surgery
* female pregnant or likely to become pregnant
* chronic drug abuse, alcoholism or psychaitric disorder within the past 2 years
* treated with beta adrenergic blockers
* on lipid lowering drugs
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abhimanyu Garg
Professor, Chairman Division Nutrition & Metabolic Diseases
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abhimanyu Garg
Role: PRINCIPAL_INVESTIGATOR
UT Southwestern Medical Center at Dallas
References
Explore related publications, articles, or registry entries linked to this study.
Shah M, Chandalia M, Adams-Huet B, Brinkley LJ, Sakhaee K, Grundy SM, Garg A. Effect of a high-fiber diet compared with a moderate-fiber diet on calcium and other mineral balances in subjects with type 2 diabetes. Diabetes Care. 2009 Jun;32(6):990-5. doi: 10.2337/dc09-0126. Epub 2009 Mar 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DF498
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.